A Randomized Controlled Study Comparing the Safety and Efficacy of Irinotecan Hydrochloride Liposome Injection Combined With Temozolomide and Vincristine (NALIRI-VT) Versus Irinotecan Combined With Temozolomide and Vincristine (VIT) in Patients With Advanced Ewing's Sarcoma

NCT07092306 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Ewing's Sarcoma

Interventions

DRUG: Irinotecan Hydrochloride Liposome Injection Combined with Temozolomide and Vincristine (NALIRI-VT)
DRUG: Irinotecan Combined with Temozolomide and Vincristine (VIT)

Sponsor

Tang Xiaodong